Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian scientists working on effective vaccines against COVID-19 and HIV: IISC
The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences
Dalmia Healthcare nod from AYUSH Ministry to manufacture Astha-15 for COVID-19 treatment
Dalmia Healthcare would be applying for permission/approval of Astha-15 usage in allopathic hospitals, as per the procedure in…
Drug developers are interested in innovative polymers and multilayer technology to help meet…
Rajarshi Datta, Country Head & General Manager - South Asia, Honeywell Advanced Materials informs there is a growing need for…
AbCellera antibody gets US FDA EUA as monotherapy for COVID-19 treatment
AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…
Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData
Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months
Dr Reddy’s presents preclinical data for E7777 (denileukin diftitox) and an immune checkpoint…
The data reveals significant improvement in tumour growth inhibition and overall survival through a combination of E7777…
Industry experts disagree with NPPA’s remark on FDCs
Experts say it is beyond the jurisdiction of NPPA
COVID-19 vaccine over 90 per cent effective: Pfizer
Pfizer and BioNTech said they have so far found no serious safety concerns and expect to seek US authorisation this month for…
Wellness Forever raises Rs 1.3 bn from Allana Group, Adar Poonawalla
The company aims to add over 150 more stores in the next year and 1000 retail outlets in the next three years
Bridge Biotherapeutics, Boehringer Ingelheim cancel agreement to develop BBT-877 for idiopathic…
Under the License Agreement, Bridge Biotherapeutics will regain all rights to BBT-877